
Please try another search
H.C. Wainwright assumed coverage on Cidara Therapeutics (NASDAQ:CDTX) Wednesday with a buy rating and a price target of $41.00, citing the company's novel approach to influenza prevention. According...
On Thursday, Citizens JMP analysts reaffirmed their Market Outperform rating for Cidara Therapeutics stock (NASDAQ: NASDAQ:CDTX) with a price target of $47.00. Currently trading at $24.05, the stock...
On Wednesday, Needham analysts increased the price target for Cidara Therapeutics (NASDAQ:CDTX) stock to $36 from the previous $35, while maintaining a Buy rating. This aligns with the broader analyst...
On Monday, JMP Securities sustained its Market Outperform rating and $47.00 price target for Cidara Therapeutics (NASDAQ:CDTX) stock, significantly above the current trading price of $21.68. According...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review